90 related articles for article (PubMed ID: 9765354)
1. Differential effects of S6 mutations on binding of quinidine and 4-aminopyridine to rat isoform of Kv1.4: common site but different factors in determining blockers' binding affinity.
Zhang H; Zhu B; Yao JA; Tseng GN
J Pharmacol Exp Ther; 1998 Oct; 287(1):332-43. PubMed ID: 9765354
[TBL] [Abstract][Full Text] [Related]
2. Different state dependencies of 4-aminopyridine binding to rKv1.4 and rKv4.2: role of the cytoplasmic halves of the fifth and sixth transmembrane segments.
Tseng GN
J Pharmacol Exp Ther; 1999 Aug; 290(2):569-77. PubMed ID: 10411564
[TBL] [Abstract][Full Text] [Related]
3. Reverse use dependence of Kv4.2 blockade by 4-aminopyridine.
Tseng GN; Jiang M; Yao JA
J Pharmacol Exp Ther; 1996 Nov; 279(2):865-76. PubMed ID: 8930194
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
Jäger H; Grissmer S
Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.
Decher N; Kumar P; Gonzalez T; Renigunta V; Sanguinetti MC
Mol Pharmacol; 2005 Oct; 68(4):995-1005. PubMed ID: 16024663
[TBL] [Abstract][Full Text] [Related]
6. Novel alpha-KTx sites in the BK channel and comparative sequence analysis reveal distinguishing features of the BK and KV channel outer pore.
Giangiacomo KM; Becker J; Garsky C; Schmalhofer W; Garcia ML; Mullmann TJ
Cell Biochem Biophys; 2008; 52(1):47-58. PubMed ID: 18815746
[TBL] [Abstract][Full Text] [Related]
7. 4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels.
Castle NA; Fadous SR; Logothetis DE; Wang GK
Mol Pharmacol; 1994 Dec; 46(6):1175-81. PubMed ID: 7808439
[TBL] [Abstract][Full Text] [Related]
8. Inactivation and recovery in Kv1.4 K+ channels: lipophilic interactions at the intracellular mouth of the pore.
Bett GC; Rasmusson RL
J Physiol; 2004 Apr; 556(Pt 1):109-20. PubMed ID: 14608006
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants of KCNQ1 channel block by a benzodiazepine.
Seebohm G; Chen J; Strutz N; Culberson C; Lerche C; Sanguinetti MC
Mol Pharmacol; 2003 Jul; 64(1):70-7. PubMed ID: 12815162
[TBL] [Abstract][Full Text] [Related]
10. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
Kurata HT; Wang Z; Fedida D
J Gen Physiol; 2004 May; 123(5):505-20. PubMed ID: 15078918
[TBL] [Abstract][Full Text] [Related]
11. Quinidine enhances and suppresses Kv1.2 from outside and inside the cell, respectively.
Tseng GN; Zhu B; Ling S; Yao JA
J Pharmacol Exp Ther; 1996 Nov; 279(2):844-55. PubMed ID: 8930192
[TBL] [Abstract][Full Text] [Related]
12. Local anesthetic block of Kv channels: role of the S6 helix and the S5-S6 linker for bupivacaine action.
Nilsson J; Madeja M; Arhem P
Mol Pharmacol; 2003 Jun; 63(6):1417-29. PubMed ID: 12761353
[TBL] [Abstract][Full Text] [Related]
13. A single residue in the S6 transmembrane domain governs the differential flecainide sensitivity of voltage-gated potassium channels.
Herrera D; Mamarbachi A; Simoes M; Parent L; Sauvé R; Wang Z; Nattel S
Mol Pharmacol; 2005 Aug; 68(2):305-16. PubMed ID: 15883204
[TBL] [Abstract][Full Text] [Related]
14. Segmental exchanges define 4-aminopyridine binding and the inner mouth of K+ pores.
Kirsch GE; Shieh CC; Drewe JA; Vener DF; Brown AM
Neuron; 1993 Sep; 11(3):503-12. PubMed ID: 8398143
[TBL] [Abstract][Full Text] [Related]
15. Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5.
Bouchard R; Fedida D
J Pharmacol Exp Ther; 1995 Nov; 275(2):864-76. PubMed ID: 7473178
[TBL] [Abstract][Full Text] [Related]
16. External barium affects the gating of KCNQ1 potassium channels and produces a pore block via two discrete sites.
Gibor G; Yakubovich D; Peretz A; Attali B
J Gen Physiol; 2004 Jul; 124(1):83-102. PubMed ID: 15226366
[TBL] [Abstract][Full Text] [Related]
17. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels.
Mouhat S; Mosbah A; Visan V; Wulff H; Delepierre M; Darbon H; Grissmer S; De Waard M; Sabatier JM
Biochem J; 2004 Jan; 377(Pt 1):25-36. PubMed ID: 12962541
[TBL] [Abstract][Full Text] [Related]
18. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
[TBL] [Abstract][Full Text] [Related]
19. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M
J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809
[TBL] [Abstract][Full Text] [Related]
20. Di-substituted cyclohexyl derivatives bind to two identical sites with positive cooperativity on the voltage-gated potassium channel, K(v)1.3.
Schmalhofer WA; Slaughter RS; Matyskiela M; Felix JP; Tang YS; Rupprecht K; Kaczorowski GJ; Garcia ML
Biochemistry; 2003 Apr; 42(16):4733-43. PubMed ID: 12705837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
